Low Rate of Hepatitis B Reactivation Among Patients with Chronic Hepatitis C During Direct Acting Antiviral Therapy.

Nehna Abdul MajeedAhmad Samer AlawadKin Seng LiemVarun TakyarHarvey AlterJordan J FeldHarry L A JanssenMarc G Ghany

Published in: Digestive diseases and sciences (2023)

The risk of HBV reactivation was low in CHC patients with resolved HBV during DAA therapy. Our data support testing for HBV DNA only in selected patients with ALT flares or failure of ALT normalization during DAA treatment.

Keyphrases

hepatitis b virus
liver failure
circulating tumor
mesenchymal stem cells
machine learning
combination therapy
cell therapy
chemotherapy induced